Research Institute

Pf-08634404 vs. Pf-08634404 + other treatments in untreated metastatic Renal Cell Carcinoma

An Interventional Phase 1b/2 Study To Evaluate The Safety And Efficacy Of Pf-08634404 Monotherapy And In Combination With Other Anticancer Agents In Adult Participants With Locally Advanced Or Metastatic Renal Cell Carcinoma

Disease Types: Renal

Available at: AlleghanyBlacksburgRoanokeSalemWytheville

An Interventional Phase 1b/2 Study To Evaluate The Safety And Efficacy Of Pf-08634404 Monotherapy And In Combination With Other Anticancer Agents In Adult Participants With Locally Advanced Or Metastatic Renal Cell Carcinoma

For More Information:

https://clinicaltrials.gov/study/NCT07227415?term=NCT07227415&rank=1